Yeast-produced recombinant virus-like particles of coxsackievirus A6 elicited protective antibodies in mice

Antiviral Research

Volumn 132, Issue , 2016, Pages 165-169

  Zhou, Yu ^a,b   Shen, Chaoyun ^b   Zhang, Chao ^b   Zhang, Wei ^b   Wang, Lili ^b   Lan, Ke ^b   Liu, Qingwei ^b   Huang, Zhong ^b  

^a SHANGHAI UNIVERSITY   (China)

^b INSTITUTE PASTEUR OF SHANGHAI   (China)

Author keywords

Coxsackievirus A6; Pichia pastoris; Vaccine; Virus like particle

Indexed keywords

3CD PROTEIN; P1 PROTEIN; PROTEIN VP0; PROTEIN VP1; PROTEIN VP3; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS LIKE PARTICLE VACCINE; VIRUS PROTEIN; VP0 ANTIBODY; VP1 ANTIBODY; VP3 ANTIBODY; NEUTRALIZING ANTIBODY; VIRAL PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS INFECTION; COXSACKIEVIRUS A6; DRUG EFFICACY; ENTEROVIRUS A; FEMALE; GENETIC TRANSFORMATION; IMMUNOGENICITY; KOMAGATAELLA PASTORIS; LETHAL DOSE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SINGLE DRUG DOSE; VACCINATION; VIRUS IMMUNITY; VIRUS LIKE AGENT; VIRUS RECOMBINANT; ANIMAL; BLOOD; DISEASE MODEL; GENETICS; IMMUNIZATION; IMMUNOLOGY; METABOLISM; SERODIAGNOSIS; YEAST;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; COXSACKIEVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ENTEROVIRUS A, HUMAN; IMMUNIZATION; MICE; NEUTRALIZATION TESTS; RECOMBINANT PROTEINS; VACCINES, VIRUS-LIKE PARTICLE; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES; YEASTS;

EID: 84975865345     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2016.06.004     Document Type: Article

References (40)

1. Ben-Chetrit, E., Wiener-Well, Y., Shulman, L.M., Cohen, M.J., Elinav, H., Sofer, D., Feldman, I., Marva, E., Wolf, D.G., Coxsackievirus A6-related hand foot and mouth disease: skin manifestations in a cluster of adult patients. J. Clin. Virol. 59 (2014), 201–203.
2. Bian, L., Wang, Y., Yao, X., Mao, Q., Xu, M., Liang, Z., Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide. Expert Rev. Anti Infect. Ther. 13 (2015), 1061–1071.
3. Blomqvist, S., Klemola, P., Kaijalainen, S., Paananen, A., Simonen, M.L., Vuorinen, T., Roivainen, M., Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. J. Clin. Virol. 48 (2010), 49–54.
4. Chackerian, B., Virus-like particles: flexible platforms for vaccine development. Expert Rev. Vaccines 6 (2007), 381–390.
5. Chong, P., Liu, C.C., Chow, Y.H., Chou, A.H., Klein, M., Review of enterovirus 71 vaccines. Clin. Infect. Dis. 60 (2015), 797–803.
6. Chung, Y.C., Ho, M.S., Wu, J.C., Chen, W.J., Huang, J.H., Chou, S.T., Hu, Y.C., Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 26 (2008), 1855–1862.
7. Downing, C., Ramirez-Fort, M.K., Doan, H.Q., Benoist, F., Oberste, M.S., Khan, F., Tyring, S.K., Coxsackievirus A6 associated hand, foot and mouth disease in adults: clinical presentation and review of the literature. J. Clin. Virol. 60 (2014), 381–386.
8. He, Y.Q., Chen, L., Xu, W.B., Yang, H., Wang, H.Z., Zong, W.P., Xian, H.X., Chen, H.L., Yao, X.J., Hu, Z.L., Luo, M., Zhang, H.L., Ma, H.W., Cheng, J.Q., Feng, Q.J., Zhao, D.J., Emergence, circulation and spatiotemporal phylogenetic analysis of Coxsackievirus A6 and Coxsackievirus A10 associated hand, foot and mouth disease infections from 2008 to 2012 in Shenzhen, China. J. Clin. Microbiol. 51 (2013), 3560–3566.
9. Hongyan, G., Chengjie, M., Qiaozhi, Y., Wenhao, H., Juan, L., Lin, P., Yanli, X., Hongshan, W., Xingwang, L., Hand, foot and mouth disease caused by coxsackievirus A6, Beijing, 2013. Pediatr. Infect. Dis. J. 33 (2014), 1302–1303.
10. Kaminska, K., Martinetti, G., Lucchini, R., Kaya, G., Mainetti, C., Coxsackievirus A6 and hand, foot and mouth disease: three case reports of familial child-to-immunocompetent adult transmission and a literature review. Case Rep. Dermatol. 5 (2013), 203–209.
11. Klein, M.H., EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines. Expert Rev. Vaccines 14 (2015), 337–340.
12. Ku, Z., Liu, Q., Ye, X., Cai, Y., Wang, X., Shi, J., Li, D., Jin, X., An, W., Huang, Z., A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice. Vaccine 32 (2014), 4296–4303.
13. Ku, Z., Ye, X., Huang, X., Cai, Y., Liu, Q., Li, Y., Su, Z., Huang, Z., Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps. PLoS One, 8, 2013, e57601.
14. Landry, M.L., Madore, H.P., Fong, C.K.Y., Hsiung, G.D., Use of Guinea-Pig embryo cell-cultures for isolation and propagation of group-a coxsackie-viruses. J. Clin. Microbiol. 13 (1981), 588–593.
15. Li, H.Y., Han, J.F., Qin, C.F., Chen, R., Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice. Vaccine 31 (2013), 3281–3287.
16. Li, J.L., Yuan, J., Yang, F., Wu, Z.Q., Hu, Y.F., Xue, Y., Zhou, B.P., Jin, Q., Epidemic characteristics of hand, foot, and mouth disease in southern China, 2013: coxsackievirus A6 has emerged as the predominant causative agent. J. Infect. 69 (2014), 299–303.
17. Liu, C.C., Chow, Y.H., Chong, P., Klein, M., Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases. Vaccine 32 (2014), 6177–6182.
18. Liu, C.C., Guo, M.S., Wu, S.R., Lin, H.Y., Yang, Y.T., Liu, W.C., Chow, Y.H., Shieh, D.B., Wang, J.R., Chong, P., Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles. Antivir. Res. 129 (2016), 58–66.
19. Liu, Q., Ku, Z., Cai, Y., Sun, B., Leng, Q., Huang, Z., Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins. J. Virol. Methods 173 (2011), 115–120.
20. Liu, Q., Yan, K., Feng, Y., Huang, X., Ku, Z., Cai, Y., Liu, F., Shi, J., Huang, Z., A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge. Vaccine 30 (2012), 6642–6648.
21. Liu, Q.W., Tong, X., Huang, Z., Towards broadly protective polyvalent vaccines against hand, foot and mouth disease. Microbes Infect. 17 (2015), 155–162.
22. Lo, S.H., Huang, Y.C., Huang, C.G., Tsao, K.C., Li, W.C., Hsieh, Y.C., Chiu, C.H., Lin, T.Y., Clinical and epidemiologic features of Coxsackievirus A6 infection in children in northern Taiwan between 2004 and 2009. J. Microbiol. Immunol. 44 (2011), 252–257.
23. Logotheti, M., Pogka, V., Horefti, E., Papadakos, K., Giannaki, M., Pangalis, A., Sgouras, D., Mentis, A., Laboratory investigation and phylogenetic analysis of enteroviruses involved in an aseptic meningitis outbreak in Greece during the summer of 2007. J. Clin. Virol. 46 (2009), 270–274.
24. Lu, J., Zeng, H., Zheng, H., Yi, L., Guo, X., Liu, L., Sun, L., Tan, X., Li, H., Ke, C., Lin, J., Hand, foot and mouth disease in Guangdong, China, in 2013: new trends in the continuing epidemic. Clin. Microbiol. Infect. 20 (2014), O442–O445.
25. Mao, Q., Wang, Y., Yao, X., Bian, L., Wu, X., Xu, M., Liang, Z., Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum. Vaccin Immunother. 10 (2014), 360–367.
26. Noad, R., Roy, P., Virus-like particles as immunogens. Trends Microbiol. 11 (2003), 438–444.
27. Osterback, R., Vuorinen, T., Linna, M., Susi, P., Hyypia, T., Waris, M., Coxsackievirus A6 and hand, foot, and mouth disease, Finland. Emerg. Infect. Dis. 15 (2009), 1485–1488.
28. Repass, G.L., Palmer, W.C., Stancampiano, F.F., Hand, foot, and mouth disease: identifying and managing an acute viral syndrome. Cleve Clin. J. Med. 81 (2014), 537–543.
29. Richter, J., Koptides, D., Tryfonos, C., Christodoulou, C., Molecular typing of enteroviruses associated with viral meningitis in Cyprus, 2000-2002. J. Med. Microbiol. 55 (2006), 1035–1041.
30. Schmidt, N.J., Ho, H.H., Lennette, E.H., Propagation and isolation of group A coxsackieviruses in RD cells. J. Clin. Microbiol. 2 (1975), 183–185.
31. Sinclair, C., Gaunt, E., Simmonds, P., Broomfield, D., Nwafor, N., Wellington, L., Templeton, K., Willocks, L., Schofield, O., Harvala, H., Atypical hand, foot, and mouth disease associated with coxsackievirus A6 infection, Edinburgh, United Kingdom, January to February 2014. Euro. Surveill., 19, 2014, 20745.
32. Tan, X., Li, L., Zhang, B., Jorba, J., Su, X., Ji, T., YaZng, D., Lv, L., Li, J., Xu, W., Molecular epidemiology of coxsackievirus A6 associated with outbreaks of hand, foot, and mouth disease in Tianjin, China, in 2013. Arch. Virol. 160 (2015), 1097–1104.
33. Vuorinen, T., Osterback, R., Kuisma, J., Ylipalosaari, P., Epididymitis caused by coxsackievirus A6 in association with hand, foot, and mouth disease. J. Clin. Microbiol. 52 (2014), 4412–4413.
34. Wang, X., Ku, Z., Dai, W., Chen, T., Ye, X., Zhang, C., Zhang, Y., Liu, Q., Jin, X., Huang, Z., A bivalent virus-like particle based vaccine induces a balanced antibody response against both enterovirus 71 and norovirus in mice. Vaccine 33 (2015), 5779–5785.
35. Wei, S.H., Huang, Y.P., Liu, M.C., Tsou, T.P., Lin, H.C., Lin, T.L., Tsai, C.Y., Chao, Y.N., Chang, L.Y., Hsu, C.M., An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan, 2010. BMC Infect. Dis., 11, 2011, 346.
36. Wong, S.S., Yip, C.C., Lau, S.K., Yuen, K.Y., Human enterovirus 71 and hand, foot and mouth disease. Epidemiol. Infect. 138 (2010), 1071–1089.
37. Xing, W., Liao, Q., Viboud, C., Zhang, J., Sun, J., Wu, J.T., Chang, Z., Liu, F., Fang, V.J., Zheng, Y., Cowling, B.J., Varma, J.K., Farrar, J.J., Leung, G.M., Yu, H., Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect. Dis. 14 (2014), 308–318.
38. Zhang, C., Ku, Z.Q., Liu, Q.W., Wang, X.L., Chen, T., Ye, X.H., Li, D.P., Jin, X., Huang, Z., High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice. Vaccine 33 (2015), 2335–2341.
39. Zhang, C., Liu, Q., Ku, Z., Hu, Y., Ye, X., Zhang, Y., Huang, Z., Coxsackievirus A16-like particles produced in Pichia pastoris elicit high-titer neutralizing antibodies and confer protection against lethal viral challenge in mice. Antivir. Res. 129 (2016), 47–51.
40. Zhao, H., Li, H.Y., Han, J.F., Deng, Y.Q., Li, Y.X., Zhu, S.Y., He, Y.L., Qin, E.D., Chen, R., Qin, C.F., Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice. Appl. Microbiol. Biotechnol. 97 (2013), 10445–10452.